Physician profile
John Brunner
NPI 1245236793
$3,192.57
in general payments reported to CMS, 2019-2025
42 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,190 · 2020: $272 · 2022: $150 · 2023: $433 · 2024: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $420.64 | 2019-2024 | Rybelsus, Ozempic |
| Sanofi-Aventis U.S. LLC | $230.77 | 2019-2023 | |
| Tandem Diabetes Care, INC. | $219.37 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Lilly USA, LLC | $189.92 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $170.00 | 2019-2020 | |
| Dexcom, INC. | $143.42 | 2019-2023 | Dexcom G6 Transmitter |
| Amgen INC. | $124.54 | 2019-2024 | Tepezza |
| Janssen Pharmaceuticals, INC | $122.05 | 2019-2020 | |
| Horizon Therapeutics Plc | $120.66 | 2020-2023 | Tepezza |
| Insulet Corporation | $88.53 | 2019 | |
| Medtronic Minimed, INC. | $84.85 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.06 | 2019-2020 | |
| Ultragenyx Pharmaceutical INC. | $77.33 | 2019-2023 | |
| Abbott Laboratories | $76.51 | 2019-2020 | |
| Shire North American Group INC | $75.35 | 2019 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Brunner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.